Go offline with the Player FM app!
Nurexone Biologic Inc
Manage episode 493123709 series 1342326
Nurexone Biologic Inc (OTCQB: NRXBF) is a TSXV, OTCQB, and Frankfurt-listed biotech company focused on developing regenerative exosome-based therapies for central nervous system injuries. Lior Shaltiel, CEO of Nurexone Biologic, joins us today to share and explain Nurexone's innovative and promising research on its lead candidate, XOP10.
330 episodes
Manage episode 493123709 series 1342326
Nurexone Biologic Inc (OTCQB: NRXBF) is a TSXV, OTCQB, and Frankfurt-listed biotech company focused on developing regenerative exosome-based therapies for central nervous system injuries. Lior Shaltiel, CEO of Nurexone Biologic, joins us today to share and explain Nurexone's innovative and promising research on its lead candidate, XOP10.
330 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.